Update on drug treatment of Parkinsonism
Winkelman, A.C.
American Family Physician 16(1): 118-120
1977
ISSN/ISBN: 0002-838X PMID: 18001 Document Number: 117829
Document emailed within 1 workday
Related Documents
Oleĭnik, L.I. 1984: Vascular parkinsonism and current methods for its drug treatment Fel'dsher i Akusherka 49(3): 33-372012: Update on current care guidelines: Treatment of drug abuse Duodecim; Laaketieteellinen Aikakauskirja 128(17): 1817-1818
Shiio, Y. 2007: Drug-induced parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 377-381
Levin, I.I. 1994: "Drug-free vacations" in parkinsonism patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 94(5): 26-28
Vestergaard, L.S.; Ringwald, P. 2007: Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies American Journal of Tropical Medicine and Hygiene 77(6 Suppl): 153-159
Small, J.G.; Kellams, J.J.; Milstein, V.; Klapper, M.; Lemberger, L. 1977: Effects of lergotrile on schizophrenia and drug induced parkinsonism Communications in Psychopharmacology 1(5): 461-467
Grimes, J.D. 1982: Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients Canadian Medical Association Journal 126(5): 468
Pavletic, Z.S.; Bishop, M.R.; Markopoulou, K.; Wszolek, Z.K. 1996: Drug-induced parkinsonism after allogeneic bone marrow transplantation Bone Marrow Transplantation 17(6): 1185-1187
Shoulson, I. 1983: Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia Advances in Neurology 37: 259-266
Lee, J.E.; Sweet, R.D.; McDowell, F.H. 1971: Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment Annals of Internal Medicine 75(5): 703-708
Court, J.; Kase, J.C.; Palacios, E.; Mena, I. 1971: Treatment of parkinsonism with L-dopa Revista Medica de Chile 99(6): 399-401
Hernández Peniche, J.; Martínez Villar, C.; De León Charles, C. 1971: Treatment of parkinsonism with L-dopa Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 23(2): 125-132
Vaĭnshtok, A.B. 1972: Treatment of parkinsonism with delagil Klinicheskaia Meditsina 50(9): 51-56
Man'kovskiĭ, N.B.; Vainshtok, A.B.; Pavlikova, R.N. 1973: Treatment of vascular parkinsonism by heparin electrophoresis Sovetskaia Meditsina 36(2): 67-72
Presthus, J. 1978: Treatment of parkinsonism today. Disappointments and new hope Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(31): 1543-1544
Ryzhkova, M.N.; Tarasova, L.A. 1975: Pathogenesis and treatment of manganese induced Parkinsonism Gigiena Truda i Professional'nye Zabolevaniya (11): 31-34
Paal, G. 1978: Clinical experiences with Nacom in the treatment of Parkinsonism Die Medizinische Welt 29(8): 320-324
Chabot, A.; Delaporte, G.; Zabourah, M.; Guillermain, S.; Laly, P.; Le Saoûlt, N. 2007: Nursing care projects in the treatment of Parkinsonism Revue de l'Infirmiere 131: 16-23
Sweet, R.D.; McDowell, F.H. 1974: The "on-off" response to chronic L-DOPA treatment of Parkinsonism Advances in Neurology 5: 331-338
Sánchez Longo, L.P.; Cruz de León, C.; Rodríguez del Valle, J.; Hernández Ortiz, T. 1971: The history of the discovery of L-dopa as treatment in parkinsonism Boletin de la Asociacion Medica de Puerto Rico 63(2): 36-40